Ascendis Pharma A (ASND) Long-Term Investments (2018 - 2026)
Ascendis Pharma A's Long-Term Investments came in at $35.43 million for the quarter ended Jun 30, 2026, down 10.3% from $39.51 million a year earlier but up 28.4% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Long-Term Investments (2018 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A's Long-Term Investments was $36.75 million, up 150.1% from the prior year.
- Long-Term Investments carries a five-year compound annual growth rate of 27.4% (years ended Dec 2020 to Dec 2025).
- Going back by year, Long-Term Investments was $14.69 million in the year ended Dec 31, 2024 (+138.9%), $6.15 million in the year ended Dec 31, 2023 (-74.6%), $24.17 million in the year ended Dec 31, 2022 (-44.9%) and $43.87 million in the year ended Dec 31, 2021 (+300.9%).
- The five-year range for quarterly Long-Term Investments is $6.12 million (the quarter ended Dec 31, 2023) to $51.46 million (the quarter ended Sep 30, 2021).
- Year-over-year, Long-Term Investments increased in six of the last eight quarters, with growth averaging 72.2%.
- The fastest year-over-year change in Long-Term Investments over five years came in the quarter ended Dec 31, 2021 (growth of 300.9%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 73.9%).
- Business Quant data shows ASND's Long-Term Investments at $27.58 million (quarter ended Mar 31, 2026), $37.86 million (quarter ended Dec 31, 2025) and $33.09 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Ascendis Pharma A | 14.12 Bn | 10.37 Bn | 362.22 Mn | 35.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.43 Mn |
| Mar 31, 2026 | 27.58 Mn |
| Dec 31, 2025 | 37.86 Mn |
| Sep 30, 2025 | 33.09 Mn |
| Jun 30, 2025 | 39.51 Mn |
| Mar 31, 2025 | 43.06 Mn |
| Dec 31, 2024 | 14.51 Mn |
| Sep 30, 2024 | 17.81 Mn |
| Jun 30, 2024 | 22.15 Mn |
| Mar 31, 2024 | 26.94 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 8.84 Mn |
| Jun 30, 2023 | 15.37 Mn |
| Mar 31, 2023 | 23.58 Mn |
| Dec 31, 2022 | 23.40 Mn |
| Sep 30, 2022 | 32.27 Mn |
| Jun 30, 2022 | 37.25 Mn |
| Mar 31, 2022 | 39.31 Mn |
| Dec 31, 2021 | 43.87 Mn |
| Sep 30, 2021 | 51.46 Mn |
API Access
Ascendis Pharma A Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();